BioMotiv, an accelerator formed out of Ohio-based University Hospitals, has announced a partnership with venture firm Torrey Pines Investment to boost new biotech firm.

Under the terms of the deal, BioMotiv will receive up to $20m to support research and development of new firms coming through its doors. In return, Torrey Piunes will have access to BioMotiv’s research networks with the aim of commercialising biotech through its ties to the pharmaceutical industry.

BioMotiv has so far received $46m from other…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?